Aspire Biopharma Holdings, Inc.
ASBP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $10,202 | $13,271 | $4,524 | $89,377 |
| - Cash | $1,948 | $206 | $1,347 | $4 |
| + Debt | $8,625 | $8,473 | $6,764 | $1,267 |
| Enterprise Value | $16,879 | $21,538 | $9,942 | $90,640 |
| Revenue | $2 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 45.5% | – | – | – |
| EBITDA | $0 | -$1,453 | -$15,651 | -$11,075 |
| % Margin | 0% | – | – | – |
| Net Income | -$1,850 | -$1,981 | -$15,941 | -$11,966 |
| % Margin | -95,337.1% | – | – | – |
| EPS Diluted | -0.037 | -0.04 | -0.33 | -0.25 |
| % Growth | 7% | 87.8% | -32% | – |
| Operating Cash Flow | -$1,104 | -$1,140 | -$1,752 | $480 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$1,104 | -$1,140 | -$1,752 | $480 |